Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,590.00    4.00 (0.09%)
Bid:
4,602.00
Ask:
4,606.00
Spread: 4.00 (0.087%)
Market Cap: £16.73b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

14 Mar 2024 14:56

RNS Number : 9289G
Coca-Cola HBC AG
14 March 2024
Β 

FOR IMMEDIATE RELEASE

14 March 2024

Β 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that on 13 March 2024, a deferred bonus award was granted to the Chief Executive Officer over shares of CHF 6.70 in the Company relating to a performance related annual bonus for 2023 under the terms of the Company's Management Incentive Plan (the "Deferred Shares"):

Β PDMR

Position

Number of Deferred Shares granted

ZORAN BOGDANOVIC

CEO

16,431

Β 

The Notification of Dealing Form can be found below.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Β 

ZORAN BOGDANOVIC

Β 

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

CHIEF EXECUTIVE OFFICER

b)

Β 

Initial notification /Amendment

Β 

INITIAL NOTIFICATION

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β 

COCA-COLA HBC AG

b)

Β 

LEI

Β 

549300EFP3TNG7JGVE49

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

SHARES

Β 

Β 

CH0198251305

b)

Β 

Nature of the transaction

Β 

Β 

GRANT OF DEFERRED SHARES UNDER THE MANAGEMENT INCENTIVE PLAN. THE NUMBER OF DEFERRED SHARES GRANTED IS EQUIVALENT TO 50 PER CENT OF THE ANNUAL BONUS AWARDED TO THE CHIEF EXECUTIVE OFFICER FOR THE 2023

FINANCIAL YEAR, CALCULATED ON THE BASIS OF THE CLOSING PRICE FOR THE DEFERRED SHARES ON THE DATE OF GRANT. THE DEFERRED SHARES WILL HAVE A VESTING PERIOD OF THREE YEARS FROM 31 DECEMBER 2023.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Volume(s)

24.75 GBP

16,431

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Price

Volume

Total

24.75 GBP

16,431

406,667.25 GBP

e)

Β 

Date of the transaction

Β 

2024-03-13

f)

Β 

Place of the transaction

Β 

OUTSIDE A TRADING VENUE

Β 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHQKQBPQBKDPND
Date   Source Headline
7th Oct 202110:44 amRNSCoca-Cola HBC completes Caffe Vergnano investment
1st Oct 20218:20 amRNSIssue of equity and total voting rights
28th Sep 20212:10 pmRNSPublication of a Prospectus
20th Sep 202111:40 amRNSDirector/PDMR Shareholding
17th Sep 20212:23 pmRNS2021 Performance Share Plan
3rd Sep 20214:05 pmRNSDirector/PDMR Shareholding
1st Sep 202111:25 amRNSDirector/PDMR Shareholding
1st Sep 202110:59 amRNSIssue of equity and total voting rights
27th Aug 20218:47 amRNSDirector/PDMR Shareholding
24th Aug 202110:09 amRNSDirector/PDMR Shareholding
18th Aug 202111:48 amRNSDirector/PDMR Shareholding
18th Aug 20219:34 amRNSDirector/PDMR Shareholding
18th Aug 20219:11 amRNSDirector/PDMR Shareholding
17th Aug 20219:15 amRNSDirector/PDMR Shareholding
12th Aug 20219:00 amRNSAcquires Coca-Cola Bottling Company of Egypt
12th Aug 20217:00 amRNSStrong momentum across all segments
10th Aug 202112:04 pmRNSDirector/PDMR Shareholding
2nd Aug 202110:20 amRNSIssue of equity and total voting rights
19th Jul 20212:44 pmRNSDirector/PDMR Shareholding
9th Jul 20213:47 pmRNSNotice of Results
1st Jul 202110:52 amRNSIssue of equity and total voting rights
28th Jun 20217:00 amRNSCCH takes minority stake in Caffè Vergnano
22nd Jun 20211:55 pmRNSComposition of the Committees of the BoD
22nd Jun 20211:19 pmRNSResult of AGM
18th Jun 20212:02 pmRNSDirector/PDMR Shareholding
10th Jun 202111:57 amRNSAthens Exchange trading date of ordinary shares
1st Jun 202111:01 amRNSIssue of equity and total voting rights
21st May 20217:00 amRNSNotice of AGM
18th May 20211:50 pmRNSDirector/PDMR Shareholding
12th May 20217:00 amRNSGood start in a challenging environment
4th May 202110:12 amRNSBlock listing Interim Review
4th May 202110:05 amRNSTotal voting rights
19th Apr 20214:34 pmRNSDirector/PDMR Shareholding
19th Apr 202112:05 pmRNSNotice of Results
1st Apr 20214:09 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:03 pmRNSElection of Home Member State
18th Mar 20215:12 pmRNSDirector/PDMR Shareholding
18th Mar 20212:26 pmRNS2020 integrated annual report 'Adapt to Win'
18th Mar 202112:52 pmRNSDirector/PDMR Shareholding
18th Mar 202112:27 pmRNSDirector/PDMR Shareholding
18th Mar 20219:50 amRNSDirector/PDMR Shareholding
1st Mar 20218:33 amRNSIssue of Equity
18th Feb 202112:14 pmRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSOperational agility delivers resilient performance
8th Feb 20212:44 pmRNSNotice of Results-New time for the analysts call
19th Jan 20212:42 pmRNSDirector/PDMR Shareholding
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding
1st Dec 202011:21 amRNSIssue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.